Anthem Biosciences shares have risen significantly since its listing. The company reported strong June quarter results, ...

Anthem Biosciences' shares have soared 46% since their listing, driven by robust financial growth and strong June quarter results.

Anthem Biosciences IPO Listing: The initial public offering (IPO) of Anthem Biosciences Ltd witnessed strong demand during its subscription period. As the Anthem Biosciences IPO allotment status is ...

Anthem Biosciences IPO Allotment: The initial public offering (IPO) of Anthem Biosciences Ltd received stellar demand from investors. As the bidding period has ended, focus now shifts on Anthem ...

India's Urban Company soars 74% in trading debut, hits about $3 billion valuation Urban Company's shares surged 74% in their trading debut on Wednesday, notching a $3 billion valuation, after one of ...

Article ‘Count’ and ‘Share’ for Anthem Biosciences Private Limited based on listed parameters only. According to the parameters selected above, there are no articles from Anthem Biosciences Private ...

The mid-cap threshold may be raised to around Rs 33,400 crore, compared with Rs 30,700 crore in the June categorisation.

Nuvama Alternative & Quantitative Research anticipates significant shifts in AMFI's upcoming stock reclassification in ...

The ₹1,900-crore IPO of Urban Company, which was open for subscription between September 10 and 12, was fully booked within a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Stay updated with the latest stock market news and live updates. Get real-time insights on Sensex Today, Nifty Live, stock market today, IPO news and more on Business Standard.